NCT01125683View on ClinicalTrials.gov

To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Alzheimer´s Disease
Interventions
DRUG

AZD1446

Capsule, oral single and multiple dose

DRUG

Donepezil

Capsule, oral and single dose

DRUG

Placebo

Capsule, oral and single dose

Trial Locations (7)

Unknown

Research Site, Kazan'

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Kiev

Research Site, Dnipropetrovsk

Research Site, Luhansk

Research Site, Vinnytsia

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY